Adjuvant Therapy for Melanoma: A Surgical Perspective

被引：12

作者：

Sondak, Vernon K. ^{[1
,2
,3
]}

Gonzalez, Ricardo J. ^{[1
,2
,4
]}

Kudchadkar, Ragini ^{[1
,2
]}

机构：

[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Cutaneous Oncol, Tampa, FL 33612 USA

[2] Univ S Florida, Coll Med, Dept Oncol Sci, Tampa, FL 33612 USA

[3] Univ S Florida, Coll Med, Dept Surg, Tampa, FL 33612 USA

[4] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Sarcoma Oncol, Tampa, FL 33612 USA

来源：

SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2011年 / 20卷 / 01期

关键词：

Melanoma; Adjuvant therapy; Interferon; Vaccines; GM-CSF; Ipilimumab; HIGH-RISK MELANOMA; ISOLATED LIMB INFUSION; COOPERATIVE-ONCOLOGY-GROUP; SENTINEL-NODE BIOPSY; DOSE INTERFERON-ALPHA-2B; STAGE-III; PEGYLATED INTERFERON-ALPHA-2B; 1.5; MM; TRIAL; PERFUSION;

D O I：

10.1016/j.soc.2010.09.001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Adjuvant therapy is commonly used in melanoma because recurrence after surgery usually results in the patient's eventual death. Surgeons have a profound influence on patients' decisions regarding adjuvant therapy, beginning with providing a clear understanding of the risk of specific types of recurrence. This review summarizes the potential oncologic benefits and relevant toxicities of adjuvant systemic therapies for melanoma that are currently available and under investigation.

引用

页码：105 / +

页数：11

共 46 条

[1] The Benefits of Adjuvant. Radiation Therapy After Therapeutic Lymphadenectomy for Clinically Advanced, High-Risk, Lymph Node-Metastatic Melanoma [J].

Agrawal, Shefali ;

Kane, John M., III ;

Guadagnolo, Beverly A. ;

Kraybill, William G. ;

Ballo, Matthew T. .

CANCER, 2009, 115 (24) :5836-5844

[2] Sentinel node biopsy and standard of care for melanoma [J].

Balch, Charles M. ;

Morton, Donald L. ;

Gershenwald, Jeffrey E. ;

McMasters, Kelly M. ;

Nieweg, Omgo E. ;

Powell, Barry ;

Ross, Merrick I. ;

Sondak, Vernon K. ;

Thompson, John F. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (05) :872-875

[3] Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system [J].

Balch, CM ;

Soong, SJ ;

Gershenwald, JE ;

Thompson, JF ;

Reintgen, DS ;

Cascinelli, N ;

Urist, M ;

McMasters, KM ;

Ross, MI ;

Kirkwood, JM ;

Atkins, MB ;

Thompson, JA ;

Coit, DG ;

Byrd, D ;

Desmond, R ;

Zhang, YT ;

Liu, PY ;

Lyman, GH ;

Morabito, A .

JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (16) :3622-3634

[4] A Multi-Institutional Experience of Isolated Limb Infusion: Defining Response and Toxicity in the US [J].

Beasley, Georgia M. ;

Caudle, Abigail ;

Petersen, Rebecca P. ;

McMahon, Nicole S. ;

Padussis, James ;

Mosca, Paul J. ;

Zager, Jonathan S. ;

Hochwald, Steven N. ;

Grobmyer, Stephen R. ;

Delman, Keith A. ;

Andtbacka, Robert H. ;

Noyes, R. Dirk ;

Kane, John M. ;

Seigler, Hilliard ;

Pruitt, Scott K. ;

Ross, Merrick I. ;

Tyler, Douglas S. .

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 208 (05) :706-715

[5] A phase II trial of isolated limb infusion with melphalan and dactinomycin for regional melanoma and soft tissue sarcoma of the extremity [J].

Brady, Mary S. ;

Brown, Karen ;

Patel, Ami ;

Fisher, Charles ;

Marx, Will .

ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (08) :1123-1129

[6]

Chapman Paul B, 2004, J Natl Compr Canc Netw, V2, P69

[7] TREATMENT OF MELANOMA BY ISOLATION-PERFUSION TECHNIQUE [J].

CREECH, O ;

RYAN, RF ;

KREMENTZ, ET .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1959, 169 (04) :339-343

[8] Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor [J].

Daud, Adil I. ;

Mirza, Noweeda ;

Lenox, Brianna ;

Andrews, Stephanie ;

Urbas, Patricia ;

Gao, Gui X. ;

Lee, Ji-Hyun ;

Sondak, Vernon K. ;

Riker, Adam I. ;

DeConti, Ronald C. ;

Gabrilovich, Dmitry .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (19) :3235-3241

[9] Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma:: final results of EORTC 18991, a randomised phase III trial [J].

Eggermont, Alexander M. M. ;

Suciu, Stefan ;

Santinami, Mario ;

Testori, Alessandro ;

Kruit, Wim H. J. ;

Marsden, Jeremy ;

Punt, Cornelis J. A. ;

Sales, Francois ;

Gore, Martin ;

MacKie, Rona ;

Kusic, Zvonko ;

Dummer, Reinhard ;

Hauschild, Axel ;

Musat, Elena ;

Spatz, Alain ;

Keilholz, Ulrich .

LANCET, 2008, 372 (9633) :117-126

[10] Adjuvant Interferon in High-Risk Melanoma: End of the Era? Reply [J].

Eggermont, Alexander M. M. ;

Bottomley, Andrew ;

Suciu, Stefan ;

Coens, Cornelis ;

Testori, Alessandro ;

Patel, Poulam ;

Spatz, Alan .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) :E17-E18

← 1 2 3 4 5 →